ARREF vs IVPAF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARREF is a Hold and IVPAF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARREF’s FA Score shows that 1 FA rating(s) are green whileIVPAF’s FA Score has 3 green FA rating(s).
- ARREF’s FA Score: 1 green, 4 red.
- IVPAF’s FA Score: 3 green, 2 red.
Price Growth
ARREF (@Other Metals/Minerals) experienced а -1.61% price change this week, while IVPAF (@Other Metals/Minerals) price change was -13.09% for the same time period.
The average weekly price growth across all stocks in the @Other Metals/Minerals industry was -2.06%. For the same industry, the average monthly price growth was -3.84%, and the average quarterly price growth was -11.22%.
Reported Earning Dates
ARREF is expected to report earnings on Feb 19, 2025.
IVPAF is expected to report earnings on Feb 19, 2025.
Industries' Descriptions
@Other Metals/Minerals (-2.06% weekly)The category includes companies that explore for, mine and extract metals, such as copper, diamonds, nickel, cobalt ore, lead, zinc and uranium. BHP, Rio Tinto and Southern Copper Corporation are major players in this space.
| ARREF | IVPAF | ARREF / IVPAF | |
| Capitalization | 202M | 12.9B | 2% |
| EBITDA | 26.9M | 404M | 7% |
| Gain YTD | 15.717 | 29.267 | 54% |
| P/E Ratio | 38.31 | 27.17 | 141% |
| Revenue | 260M | 0 | - |
| Total Cash | 43.9M | 484M | 9% |
| Total Debt | 26.4M | 532M | 5% |
ARREF | IVPAF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 56 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 39 | 14 | |
SMR RATING 1..100 | 49 | 22 | |
PRICE GROWTH RATING 1..100 | 58 | 54 | |
P/E GROWTH RATING 1..100 | 100 | 10 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ARREF's Valuation (3) in the null industry is significantly better than the same rating for IVPAF (93). This means that ARREF’s stock grew significantly faster than IVPAF’s over the last 12 months.
IVPAF's Profit vs Risk Rating (14) in the null industry is in the same range as ARREF (39). This means that IVPAF’s stock grew similarly to ARREF’s over the last 12 months.
IVPAF's SMR Rating (22) in the null industry is in the same range as ARREF (49). This means that IVPAF’s stock grew similarly to ARREF’s over the last 12 months.
IVPAF's Price Growth Rating (54) in the null industry is in the same range as ARREF (58). This means that IVPAF’s stock grew similarly to ARREF’s over the last 12 months.
IVPAF's P/E Growth Rating (10) in the null industry is significantly better than the same rating for ARREF (100). This means that IVPAF’s stock grew significantly faster than ARREF’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
ARREF and
Correlation & Price change
A.I.dvisor indicates that over the last year, ARREF has been loosely correlated with LUNMF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ARREF jumps, then LUNMF could also see price increases.
| Ticker / NAME | Correlation To ARREF | 1D Price Change % | ||
|---|---|---|---|---|
| ARREF | 100% | +2.52% | ||
| LUNMF - ARREF | 54% Loosely correlated | +3.01% | ||
| IVPAF - ARREF | 52% Loosely correlated | -0.03% | ||
| CSCCF - ARREF | 48% Loosely correlated | +1.10% | ||
| GLNCY - ARREF | 45% Loosely correlated | -0.36% | ||
| GLCNF - ARREF | 45% Loosely correlated | -0.18% | ||
More | ||||
IVPAF and
Correlation & Price change
A.I.dvisor indicates that over the last year, IVPAF has been closely correlated with LUNMF. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVPAF jumps, then LUNMF could also see price increases.
| Ticker / NAME | Correlation To IVPAF | 1D Price Change % | ||
|---|---|---|---|---|
| IVPAF | 100% | -0.03% | ||
| LUNMF - IVPAF | 74% Closely correlated | +3.01% | ||
| CSCCF - IVPAF | 71% Closely correlated | +1.10% | ||
| GLNCY - IVPAF | 62% Loosely correlated | -0.36% | ||
| GLCNF - IVPAF | 57% Loosely correlated | -0.18% | ||
| GMBXF - IVPAF | 53% Loosely correlated | +0.53% | ||
More | ||||